Delivery Order SPE2DE24DA010-SPE2D626F99B8
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $28,350 on January 7, 2026, by the Defense Logistics Agency's Medical Supply Chain. This fixed-price contract with economic price adjustment is scheduled for completion by January 20, 2026, and will be performed in Santa Clara, California. The delivery order carries no set-aside designation and was awarded through full and open competition, reflecting Abbott's established competitive...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $24,350 on November 25, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment is scheduled for completion by December 2, 2025, and will be performed in Santa Clara, California. The award utilized full and open competition with no set-aside designation, consistent with Abbott Vascular's established competitive...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $24,350 by the Defense Logistics Agency's Medical Supply Chain on November 14, 2025, with an ultimate completion date of November 19, 2025. The delivery order, which carries no set-aside designation, will be performed in Santa Clara, California. This award represents a task order issued under Abbott's existing $117.1 million Indefinite Delivery Contract with the Defense...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $26,480.13 by the Defense Logistics Agency's Medical Supply Chain on December 1, 2025, with an ultimate completion date of December 4, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation and will be performed in Santa Clara, California. The award represents a task order under Abbott's established relationship with the Defense Logistics...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $24,350 by the Defense Logistics Agency's Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 5, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting Abbott's competitive positioning among qualified federal contractors. Performance will take place in...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $11,750 on November 4, 2025, by the Defense Logistics Agency's Medical Supply Chain for cardiovascular medical devices and related technologies. The contract, which is not set-aside and operates under a fixed-price structure with economic price adjustment provisions, is scheduled for completion by November 7, 2025, with performance taking place in Santa Clara, California. This delivery...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order award valued at $28,350 from the Defense Logistics Agency's Medical Supply Chain on January 7, 2026, with an ultimate completion date of January 20, 2026. The contract utilizes a fixed-price structure with economic price adjustment provisions and carries no set-aside designation, reflecting full and open competition. Performance will take place in Santa Clara, California, where Abbott maintains...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order award valued at $24,350 from the Defense Logistics Agency Medical Supply Chain on December 18, 2025, with an ultimate completion date of December 23, 2025. The contract employs a fixed-price structure with economic price adjustment terms and carries no set-aside designation, reflecting full and open competition. Performance will occur at Abbott Vascular's Santa Clara, California location. This delivery...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $5,695 by the Defense Logistics Agency's Medical Supply Chain on December 11, 2025, with an ultimate completion date of January 6, 2026. This fixed-price delivery order with economic price adjustment carries no set-aside designation and represents a task order executed under Abbott's existing $117.1 million Indefinite Delivery Contract with the Defense Logistics Agency for comprehensive...
- Abbott Laboratories Inc.'s Abbott Vascular Inc. division received a delivery order award valued at $8,901.70 from the Defense Logistics Agency's Medical Supply Chain on December 5, 2025, with an ultimate completion date of December 10, 2025. This fixed-price contract with economic price adjustment carries no set-aside designation and is for performance in Santa Clara, California. The delivery order represents a task order against Abbott Vascular's larger Indefinite Delivery Contract with the...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D626F99B8Delivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $17,803.40 on January 9, 2026, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment authority is scheduled for ultimate completion by January 14, 2026, and will be performed in Santa Clara, California. The award was made through full and open competition with no set-aside designation, reflecting Abbott's competitive positioning as a qualified federal contractor in the cardiovascular medical device sector. This delivery order represents a task order issued against Abbott's broader Indefinite Delivery Contract with the Defense Logistics Agency, which carries a ceiling value of $117.1 million and provides comprehensive cardiovascular procedural packages including devices, instrumentation, accessories, and related medical technologies. Abbott Vascular has established itself as a critical supplier to federal healthcare systems, particularly the Department of Veterans Affairs and Department of Defense, providing advanced cardiovascular implants such as stents, pacemakers, heart valves, left ventricular assist devices, and transcatheter valve repair systems that support complex medical procedures across military and veteran healthcare networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.8k | 1/8/26 |